Cargando…

The clinical, immunological and genetic features of 12 Chinese patients with STAT3 mutations

BACKGROUND: Loss-of-function (LOF) mutations in signal transducer and activator of transcription 3 (STAT3) is one of the causes of STAT3 hyperimmunoglobulin E (IgE) syndrome (STAT3-HIES), while gain-of-function (GOF) mutations in STAT3 lead to immune dysregulation diseases. We retrospectively analyz...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Li, Wang, Ying, Sun, Bijun, Liu, Luyao, Ying, Wenjing, Wang, Wenjie, Zhou, Qinhua, Hou, Jia, Yao, Haili, Hu, Liyuan, Sun, Jinqiao, Wang, Xiaochuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7491347/
https://www.ncbi.nlm.nih.gov/pubmed/32944025
http://dx.doi.org/10.1186/s13223-020-00462-w
_version_ 1783582203448393728
author Lin, Li
Wang, Ying
Sun, Bijun
Liu, Luyao
Ying, Wenjing
Wang, Wenjie
Zhou, Qinhua
Hou, Jia
Yao, Haili
Hu, Liyuan
Sun, Jinqiao
Wang, Xiaochuan
author_facet Lin, Li
Wang, Ying
Sun, Bijun
Liu, Luyao
Ying, Wenjing
Wang, Wenjie
Zhou, Qinhua
Hou, Jia
Yao, Haili
Hu, Liyuan
Sun, Jinqiao
Wang, Xiaochuan
author_sort Lin, Li
collection PubMed
description BACKGROUND: Loss-of-function (LOF) mutations in signal transducer and activator of transcription 3 (STAT3) is one of the causes of STAT3 hyperimmunoglobulin E (IgE) syndrome (STAT3-HIES), while gain-of-function (GOF) mutations in STAT3 lead to immune dysregulation diseases. We retrospectively analyzed the age, common clinical symptoms, immunologic and molecular manifestations in 11 patients with LOF STAT3 mutations and 1 patient with a GOF STAT3 mutation. METHODS: Twelve patients were enrolled in our study. Serum immunoglobulin measurements, lymphocyte subset detection and whole-exome sequencing were performed. RESULTS: The median age at diagnosis of STAT3-HIES patients was 4.74 years. Eczema, recurrent respiratory infections, fevers, abscesses and Staphylococcus aureus infections were the classic manifestations. Elevated serum IgE levels are not always observed in conjunction with high eosinophil counts. A moderate viral DNA load was also measured in peripheral blood mononuclear cells. We noticed that c. 1144C>T was the most common mutation site, followed by c.1311C>A. Additionally, c.1311C>A and c. 1826G>C are two novel mutations. Eight patients achieved notable improvement after receiving intravenous immunoglobulin. CONCLUSION: We updated the current knowledge of this topic. We found an earlier median age at diagnosis, a higher survival rate, and a general lack of nonimmunological abnormalities; we also described the treatment details and novel mutations involve in STAT3-HIES and compared STAT3 LOF and GOF mutations.
format Online
Article
Text
id pubmed-7491347
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-74913472020-09-16 The clinical, immunological and genetic features of 12 Chinese patients with STAT3 mutations Lin, Li Wang, Ying Sun, Bijun Liu, Luyao Ying, Wenjing Wang, Wenjie Zhou, Qinhua Hou, Jia Yao, Haili Hu, Liyuan Sun, Jinqiao Wang, Xiaochuan Allergy Asthma Clin Immunol Research BACKGROUND: Loss-of-function (LOF) mutations in signal transducer and activator of transcription 3 (STAT3) is one of the causes of STAT3 hyperimmunoglobulin E (IgE) syndrome (STAT3-HIES), while gain-of-function (GOF) mutations in STAT3 lead to immune dysregulation diseases. We retrospectively analyzed the age, common clinical symptoms, immunologic and molecular manifestations in 11 patients with LOF STAT3 mutations and 1 patient with a GOF STAT3 mutation. METHODS: Twelve patients were enrolled in our study. Serum immunoglobulin measurements, lymphocyte subset detection and whole-exome sequencing were performed. RESULTS: The median age at diagnosis of STAT3-HIES patients was 4.74 years. Eczema, recurrent respiratory infections, fevers, abscesses and Staphylococcus aureus infections were the classic manifestations. Elevated serum IgE levels are not always observed in conjunction with high eosinophil counts. A moderate viral DNA load was also measured in peripheral blood mononuclear cells. We noticed that c. 1144C>T was the most common mutation site, followed by c.1311C>A. Additionally, c.1311C>A and c. 1826G>C are two novel mutations. Eight patients achieved notable improvement after receiving intravenous immunoglobulin. CONCLUSION: We updated the current knowledge of this topic. We found an earlier median age at diagnosis, a higher survival rate, and a general lack of nonimmunological abnormalities; we also described the treatment details and novel mutations involve in STAT3-HIES and compared STAT3 LOF and GOF mutations. BioMed Central 2020-07-22 /pmc/articles/PMC7491347/ /pubmed/32944025 http://dx.doi.org/10.1186/s13223-020-00462-w Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Lin, Li
Wang, Ying
Sun, Bijun
Liu, Luyao
Ying, Wenjing
Wang, Wenjie
Zhou, Qinhua
Hou, Jia
Yao, Haili
Hu, Liyuan
Sun, Jinqiao
Wang, Xiaochuan
The clinical, immunological and genetic features of 12 Chinese patients with STAT3 mutations
title The clinical, immunological and genetic features of 12 Chinese patients with STAT3 mutations
title_full The clinical, immunological and genetic features of 12 Chinese patients with STAT3 mutations
title_fullStr The clinical, immunological and genetic features of 12 Chinese patients with STAT3 mutations
title_full_unstemmed The clinical, immunological and genetic features of 12 Chinese patients with STAT3 mutations
title_short The clinical, immunological and genetic features of 12 Chinese patients with STAT3 mutations
title_sort clinical, immunological and genetic features of 12 chinese patients with stat3 mutations
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7491347/
https://www.ncbi.nlm.nih.gov/pubmed/32944025
http://dx.doi.org/10.1186/s13223-020-00462-w
work_keys_str_mv AT linli theclinicalimmunologicalandgeneticfeaturesof12chinesepatientswithstat3mutations
AT wangying theclinicalimmunologicalandgeneticfeaturesof12chinesepatientswithstat3mutations
AT sunbijun theclinicalimmunologicalandgeneticfeaturesof12chinesepatientswithstat3mutations
AT liuluyao theclinicalimmunologicalandgeneticfeaturesof12chinesepatientswithstat3mutations
AT yingwenjing theclinicalimmunologicalandgeneticfeaturesof12chinesepatientswithstat3mutations
AT wangwenjie theclinicalimmunologicalandgeneticfeaturesof12chinesepatientswithstat3mutations
AT zhouqinhua theclinicalimmunologicalandgeneticfeaturesof12chinesepatientswithstat3mutations
AT houjia theclinicalimmunologicalandgeneticfeaturesof12chinesepatientswithstat3mutations
AT yaohaili theclinicalimmunologicalandgeneticfeaturesof12chinesepatientswithstat3mutations
AT huliyuan theclinicalimmunologicalandgeneticfeaturesof12chinesepatientswithstat3mutations
AT sunjinqiao theclinicalimmunologicalandgeneticfeaturesof12chinesepatientswithstat3mutations
AT wangxiaochuan theclinicalimmunologicalandgeneticfeaturesof12chinesepatientswithstat3mutations
AT linli clinicalimmunologicalandgeneticfeaturesof12chinesepatientswithstat3mutations
AT wangying clinicalimmunologicalandgeneticfeaturesof12chinesepatientswithstat3mutations
AT sunbijun clinicalimmunologicalandgeneticfeaturesof12chinesepatientswithstat3mutations
AT liuluyao clinicalimmunologicalandgeneticfeaturesof12chinesepatientswithstat3mutations
AT yingwenjing clinicalimmunologicalandgeneticfeaturesof12chinesepatientswithstat3mutations
AT wangwenjie clinicalimmunologicalandgeneticfeaturesof12chinesepatientswithstat3mutations
AT zhouqinhua clinicalimmunologicalandgeneticfeaturesof12chinesepatientswithstat3mutations
AT houjia clinicalimmunologicalandgeneticfeaturesof12chinesepatientswithstat3mutations
AT yaohaili clinicalimmunologicalandgeneticfeaturesof12chinesepatientswithstat3mutations
AT huliyuan clinicalimmunologicalandgeneticfeaturesof12chinesepatientswithstat3mutations
AT sunjinqiao clinicalimmunologicalandgeneticfeaturesof12chinesepatientswithstat3mutations
AT wangxiaochuan clinicalimmunologicalandgeneticfeaturesof12chinesepatientswithstat3mutations